Join Our Crew

Sr. Project Coordinator, Science & Technology

About the Position

Reporting to the R&D Operations Director and supporting the staff within Science and Technology, the Senior Project Coordinator will be responsible for providing organizational support that will contribute to the development and operations of an engaged, high-performance organization, focused on the development of first-in-class therapies for autoimmune diseases. This person will support project leads and project managers in meeting company objectives related to Cabaletta’s therapeutic pipeline by ensuring efficiency in meetings, alignment across functional groups, and clear communication of the status of work as aligned with company strategy, commitments,and goals. This position requires an excellent grasp of administrative tasks and project coordination and provides an opportunity to master project management skills required for certification.

Responsibilities Include

Science and Technology Project Coordination

  • Coordination of cross-functional internal meetings including scheduling, agenda and material preparation, distribution of minutes and ensuring timely responses on deliverables.
  • Curate and store project-specific correspondences, reports, and meeting decks, taking ownership of administrative organizational processes and templates for future knowledge transfer and usage.
  • In collaboration with project leads or functional heads, interface with external stakeholders from critical collaborator partnerships, schedule and guide meeting preparation for governance meetings; prepare materials and facilitate project team meetings, distribute and archive minutes.
  • Support Science & Technology staff with calendar coordination, meeting materials and minutes, conference attendance, team debriefs, travel plans, and continued education for professional development.
  • Support Alliance Management, track new and executed contracts, and develop vendor oversight management template for managing critical external collaborators.

Science and Technology Project Management

  • Support R&D Operations Director on developing and maintaining product development plans for lead disease programs.
  • Support or lead creation and maintenance of project timelines and project-specific files, and track/report progress in partnership with pipeline program project leaders.
  • Facilitate planning and implementation of projects that support platform related to the manufacturing improvements, implementing new technologies and facilities planning.
  • Collaboratively create and manage lab objectives, tracking progress and changes, and communicating this status broadly.
  • Increase organizational proficiency in MS Project, Smartsheet and ThinkCell, and interface with staff to increase awareness, accuracy, and usage of PM tools.

Required Qualifications

  • Bachelors or Masters degree in scientific field required, CAPM desirable
  • 2-5 years’ combined experience doing research or managing projects in scientific field
  • 1-2 years project coordination and experience with project management tools required, combined with strong administrative skills.
  • Previous experience or passion within technical and scientific fields within cell and gene therapy drug development.
  • Proficiency in MS Office (MS Outlook, PowerPoint, Excel and Word), Smartsheet, MS Project, remote access meeting and data sharing platforms
  • Strong time management skills and ability to multi-task and prioritize work
  • Attention to detail and problem-solving skills
  • Strong written and verbal communication skills, with ability to build credibility and influence colleagues at all levels
  • Strong organizations skills, with a desire to enhance leadership skills

How to Apply

Please email careers@cabalettabio.com directly to submit an application.

Please include your CV along with the title of the position you are applying for.

Benefits

Our most important asset is our people and we offer competitive benefits including health and retirement, PTO, and stock option plans.

Equal Opportunity Employer

Cabaletta Bio is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law.

About Cabaletta Bio

Cabaletta Bio (NASDAQ: CABA) is focused on the discovery and development of T cell therapies for B cell-mediated autoimmune diseases. Our proprietary technology utilizes Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to precisely bind and destroy only specific autoantibody-expressing B cells while sparing normal antibody-expressing B cells, which are essential for human health. Cabaletta’s Approach for selective B cell Ablation platform, called our CABA™ platform, has applicability across more than two dozen B cell-mediated autoimmune diseases that we have identified, reviewed and prioritized. CAAR T technology is based on the revolutionary Chimeric Antigen Receptor (CAR) T cell technology developed at the University of Pennsylvania that resulted in one of the first commercially-available CAR T cell products for the treatment of B cell malignancies. Cabaletta has an exclusive global licensing agreement and multiple sponsored research agreements with the University of Pennsylvania to develop CAAR T technology to treat B cell-mediated autoimmune diseases.

The Company’s lead product candidate, DSG3-CAART, received IND clearance from the FDA in September 2019, and initial safety data in clinical trials has been reported. DSG3-CAART is designed to be a potential treatment for patients with mucosal pemphigus vulgaris (mPV), which is a rare autoimmune blistering disorder that causes painful blisters and sores on mucous membranes leading to severe and sometimes debilitating and life-altering effects. Cabaletta Bio is also pursuing additional pipeline candidates for other B cell mediated disorders including MuSK Myasthenia Gravis (MG) with an IND planned for 2H 2021, mucocutaneous PV, PLA2R positive membranous nephropathy (PMN), and Factor VIII inhibitors.

Uniquely Differentiated. Rapid. Elegant.

At Cabaletta, we are driven by the shared mission of developing a new type of therapy, where patients’ own cells are used to fight disease. We are building a culture grounded in the knowledge that success in the Cabaletta mission lies in the hands of individuals across every aspect of the company. To nurture this, we make an active commitment to the well-being and continuous growth of each person who joins our team. In this way, we are not only working to improve the lives of patients, but of everyone involved. #CabalettaCrew